NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002312

Registered date:10/08/2009

Multicenter diagnostic study for IgG4+MOLPS, Castleman's disease, and other polyclonal hypergammopathies

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedIgG4+MOLPS, Castleman's disease, other polyclonal hypergammopathies, male Sjogen's syndrome
Date of first enrollment2009/08/01
Target sample size100
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeDefinition of diagnostic criteria of IgG4+MOLPS; assessment of glucocorticoid response.
Secondary OutcomeCollection of clinical data, tissue, serum and lymphocytes. Proteomics and genomics analysis.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaDistinct monoclonal gammopathy such as Myeloma, Macroglobulinemia.

Related Information

Contact

public contact
Name Yasufumi Masaki
Address 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa Japan
Telephone 076-286-3511
E-mail yasum@kanazawa-med.ac.jp
Affiliation Kanazawa Medical University Hematology & Immunology
scientific contact
Name Yasufumi Masaki
Address 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa Japan
Telephone 076-286-3511
E-mail
Affiliation Kanazawa Medical University Hematology & Immunology